Advertisement

The Role of Red Cell Aging in the Diagnosis of Glycolytic Enzyme Defects

  • Gerard E. J. Staal
  • Gert Rijksen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 307)

Abstract

During the development from stem cell to mature erythrocyte, the human red cell loses several of its metabolic and synthetic capacities. The mature red cell is devoid of DNA and RNA and therefore lacks the possibility of protein synthesis. With respect to metabolism, the disappearance of mitochondria and ribosomes deprives the erythroid cell from obtaining energy through oxydative phosphorylation and from renewed enzyme required in metabolic processes. As a consequence the mature red cell is almost completely dependent upon anaerobic glycolysis as a source of energy supply during its 120 day mean life span. Despite the limited metabolic capacity of the glycolytic pathway in the mature erythrocyte sufficient ATP is available for processes involved in its optimal functioning i.e. keeping the haem iron in the reduced state, synthesis of glutathione, maintaining the electrochemical gradients over the plasma membrane, salvage of purine nucleotides and protection of hemoglobin against methemoglobin formation and oxidative denaturation. In reticulocytes the energy consumption pattern is completely different. First of all the production of ATP is about 100 times higher than in mature erythrocytes, partly by increased glycolytic enzyme activities and further by a still intact oxidative phosphorylation. The increased activities of glycolytic enzymes in young red cell fractions predominantly concern those of hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase. The increased enzyme activities are linearly correlated with the reticulocyte counts in these fractions. This finding suggests that the presumed age dependency of these enzymes is mainly related to reticulocyte maturation. In patients with hemolytic anemia the diagnosis of a deficiency of one of these enzymes may be masked by an increased reticulocyte number. On the other hand in patients with severe transfusiondependent hemolytic anemia, the diagnosis of an erythrocyte enzymopathy is often troubled by the presence of relatively large amounts of donor erythrocytes with normal enzyme activities. In this paper we present a few examples, mainly concerning abnormal pyruvate kinase, illustrating the above mentioned problems, in the diagnosis of an enzymopathy.

Keywords

Hemolytic Anemia Pyruvate Kinase Reticulocyte Count Pyruvate Kinase Activity Lower Density Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    H. Chr. Benöhr, and H. D. Waller, Metabolism in hemolytic states, Clin. Haematol., 4:45 (1975).PubMedGoogle Scholar
  2. 2.
    G. Rijksen, J.-W. N. Akkerman, A. W. L. van den Wall, D. Pott hofstede, and G. E. J. Staal, Generalized Hexokinase deficiency in the blood cells of a patient with non-spherocytic hemolytic anemia, Blood, 61:12 (1983).PubMedGoogle Scholar
  3. 3.
    G. E. J. Staal and G. Rijksen, Regulation of pyruvate kinase in normal and pathological conditions, in “Regulation of Carbohydrate metabolism”, R. Beitner, ed., vol. 1:143, CRC Press, Boca Raton (1985).Google Scholar
  4. 4.
    K. Imamura, K. Taniuchi and T. Tanaka. Multimolecular forms of pyruvate kinase, J. Biochem. 71:1001 (1972).Google Scholar
  5. 5.
    G. E. J. Staal, G. Rijksen, A. M. C. Vlug, B. Vromen-van den Bos, J.-W. N. Akkerman, G. Gorter, J. Dierick and M. Petermans. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression, Clin. Chim. Acta 118:241 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    J. Marie, M. P. Simon, J. C. Dreyfus and A. Kahn, One gene, but two messenger RNAs encode liver L and red Cell L’ pyruvate kinase subunits, Nature 292:70 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    M. Cognet, Y. C. Lone, S. Vaulont, A. Kahn and J. Marie, Structure of the rat L-type pyruvate kinase gene, J. Mol. Biol. 196:11 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    G. L. Tremp, J. Boquet, A. Kahn and D. Doegelen, Expression of the rat L-type pyruvate kinase gene from its dual erythroid and liver specific promoter in transgene mice, J. Biol. Chem. 264:19904 (1989).PubMedGoogle Scholar
  9. 9.
    T. Noguchi, H. Inone and T. Tanaka, The M-and M-types isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J. Biol. Chem. 261:13807 (1986).PubMedGoogle Scholar
  10. 10.
    G. Rijksen, A. J. P. Veerman, G.P.M. Schipper-kester and G. E. J. Staal, Diagnosis of pyruvate kinase deficiency in a transfusion dependent patient with severe hemolytic anemia, American J. of Hematology (1990) in press.Google Scholar
  11. 11.
    C. M. Rennie, S. Thompson, A. C. Parker, A. Maddy, Human erythrocyte fraction in “Percoll” density gradients, Clin. Chim. Acta 98:119 (1979).PubMedCrossRefGoogle Scholar
  12. 12.
    H. E. van Erp, P. J. M. Roholl, E.D. Sprengers, C. W. M. van Veelen, G.E. J. Staal, Production and characteriztion of monoclonal antibodies against human L-type pyruvate kinase, Eur. J. Cell Biol. 47:388 (1988).PubMedGoogle Scholar
  13. 13.
    G. E. J. Staal, G. Jansen and D. Roos, Pyruvate kinase and the “High ATP syndrome”, J. Clin.Invest. 74:231 (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    G. E. J. Staal, J. F. Koster, H. Hamp, L. Van Milligen-Boersma and C. Veeger, Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim. Biophys. Acta 227:86 (1971).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Gerard E. J. Staal
    • 1
  • Gert Rijksen
    • 1
  1. 1.Department of Haematology Lab. Med. EnzymologyUniversity Hospital UtrechtUtrechtThe Netherlands

Personalised recommendations